STAR
Strides Pharma Science
Each stock's 10,000-path forecast, rendered as light.
Strides Pharma Science (STAR) Stock Analysis & Case Study
Is STAR a good buy? The data-driven verdict.
on the numbers it tread carefully, a Downstox Snapshot Score of 39/100.
On the numbers, Strides Pharma Science (STAR) tread carefully, a Downstox Snapshot Score of 39/100, weighing a 40% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
STAR share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of STAR history (8%/yr drift, 71%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| STAR 2027 | ₹387 | ₹923 | ₹2,296 | -17% |
| STAR 2028 | ₹214 | ₹795 | ₹2,831 | -28% |
| STAR 2029 | ₹137 | ₹668 | ₹3,313 | -40% |
| STAR 2030 | ₹91 | ₹565 | ₹3,549 | -49% |
| STAR 2031 | ₹61 | ₹477 | ₹3,704 | -57% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability STAR goes up, or doubles?
The bull case for STAR
- Strides Pharma Science is part of the NSE universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹3,313.
The bear case & risks
- The probability model is cautious 12 months out, only a 40% chance of finishing above today's price.
- High historical volatility (71%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹137.
STAR volatility & expected range, how bumpy is the ride?
Over the last 2.0 years STAR compounded at 8%/year with annualized volatility of 71%. That volatility implies a 1-year 80% range of ₹387–₹2,296, the honest backbone behind any single price target.
STAR price forecast, the full 60-month probability fan
STAR price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds STAR hits common targets within the simulated horizon?
Full multi-horizon detail on the STAR price target & forecast page.
STAR MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy STAR with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.0% | 2.9× |
| ZerodhaCHEAPEST | 34.4% | 2.9× |
| DhanCHEAPEST | 34.4% | 2.9× |
Compare every broker on the STAR MTF page.
STAR vs peers,sector comparison
About Strides Pharma Science: sector, index & market-cap context
Strides Pharma Science (STAR) is an NSE-listed company.
How the STAR Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Strides Pharma Science's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
STAR analysis, FAQs
Is Strides Pharma Science (STAR) a good buy?
On the numbers, Strides Pharma Science (STAR) tread carefully, a Downstox Snapshot Score of 39/100, weighing a 40% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is STAR overvalued or undervalued?
Valuation ratios for STAR are tracked live on Downstox.
What is the STAR share price target for 2031?
STAR's probability-weighted 2031 median target is ₹477, with an 80% range of ₹61–₹3,704 (10,000-path Monte-Carlo).
What is the probability STAR doubles in 5 years?
The modelled probability of STAR reaching ₹2,222 (2×) within 5 years is 17%.
What is the bull case for STAR?
Strides Pharma Science is part of the NSE universe with live, tracked fundamentals on Downstox.
What are the risks in STAR?
The probability model is cautious 12 months out, only a 40% chance of finishing above today's price. High historical volatility (71%/yr) means a wide, bumpy range of outcomes, size positions accordingly.